por
Loren Bonner, DOTmed News Online Editor | March 19, 2013
"There is lots of growth in Mexico right now," said Shrawder.
But there are challenges in these countries too. While it's a good thing that many developing countries are instituting safety standards after years of the absence of any regulation — often at the risk of jeopardizing the public's health — some regulatory barriers have made it difficult for OEMs to do business. For example, since 1999, the year Agência Nacional de Vigilância Sanitária (Anvisa), the equivalent of the FDA in Brazil, was created, there have been
challenges with the registration process for U.S. OEMs.
Ad Statistics
Times Displayed: 129813
Times Visited: 7378 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
"Where GE would like to be on this is to support and encourage responsible regulation of health care but not in a manner that is random and completely independent of other global standards and not in a way that is blatantly protectionist either," said Shrawder.
He made it clear that GE Healthcare does not want to manufacture in Brazil to take advantage of any protectionism but to instead "get closer to our customers."
Back to HCB News
